TAVR

PARTNER to 5 years. TAVR is an effective alternative to surgery in high risk patients

This study included 699 patients with severe aortic stenosis and high surgical risk of whom 348 received transcatheter aortic valve replacement (TAVR) and 351 received surgery. Previous reports of the results to one, two and three years and this work published simultaneously in Lancet reports the final follow-up at 5 years. The mortality at follow-up<a href="https://solaci.org/en/2015/06/24/partner-to-5-years-tavr-is-an-effective-alternative-to-surgery-in-high-risk-patients/" title="Read more" >...</a>

Promising results of TAVR in Bicuspid Aortic

Original title:&nbsp;Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve Disease.&nbsp;Reference:&nbsp;Darren Mylotte, et al. J Am Coll Cardiol 2014;64:2330-9 The bicuspid aortic valve (BAV) is present between 0.5% and 2% of the general population and up to 20% of patients older than 80 years who require aortic valve surgery. Literature on &nbsp; &nbsp; transcatheter aortic valve<a href="https://solaci.org/en/2015/01/08/promising-results-of-tavr-in-bicuspid-aortic/" title="Read more" >...</a>

TAVR minimally invasive, shorter hospital stay and costs without compromising safety or efficacy

Original title:&nbsp;Comparison of Transfemoral TranscatheterAortic Valve Replacement Performedin the Catheterization Laboratory(Minimalist Approach) Versus HybridOperating Room (Standard Approach). Outcomes and CostAnalysis.&nbsp;Reference:&nbsp;VasilisBabaliaros et al. J Am CollCardiolIntv 2014;7:898&ndash;904. This retrospective study of a center analyzed the results of percutaneous aortic valve replacement (TAVR) performed with a minimally invasive technique that included the closure of the femoral access<a href="https://solaci.org/en/2014/08/25/tavr-minimally-invasive-shorter-hospital-stay-and-costs-without-compromising-safety-or-efficacy/" title="Read more" >...</a>

TAVR: Regression of Left Ventricular Hypertrophy Decreases Re-hospitalization

Original title:&nbsp;Early Regression of Severe Left Ventricular Hypertrophy After Transcatheter Aortic Valve Replacement Is Associated with Decreased Hospitalization.&nbsp;Reference:&nbsp;Brian Lindman, et al. JACC Cardiovasc Interv 2014;7:662-73. &nbsp; Left ventricular hypertrophy, defined by the increase of left ventricular mass, has long been associated to increased morbi-mortality in the context of different heart conditions. LV hypertrophy regression might<a href="https://solaci.org/en/2014/08/05/tavr-regression-of-left-ventricular-hypertrophy-decreases-re-hospitalization/" title="Read more" >...</a>

Fully percutaneous vs. surgical transfemoral TAVR: similar major vascular complications rate and shorter hospital stay.

Original title:&nbsp;Factors associated with vascular complications in patients undergoing balloon-expandable transfemoral transcatheter aortic valve replacement via open versus percutaneous approaches.&nbsp;Reference:&nbsp;Kadakia MB et al. Circ Cardiovasc Interv. 2014; Epub ahead of print. &nbsp; This retrospective study included 331 patients undergoing transfemoral TAVR in one center between 2007 and 2013. 64% of the population were treated with<a href="https://solaci.org/en/2014/07/28/fully-percutaneous-vs-surgical-transfemoral-tavr-similar-major-vascular-complications-rate-and-shorter-hospital-stay/" title="Read more" >...</a>

Non-ST-Segment Elevation Myocardial Infarction in Elderly Patients

The world population is aging, and cardiovascular diseases are the leading cause of death in Western countries.&nbsp; It is increasingly common to find patients aged 70 or older with non-ST-segment elevation acute myocardial infarction (NSTEMI). However, this group has been excluded from most studies, and there is not enough information to determine whether a conservative<a href="https://solaci.org/en/2024/07/01/non-st-segment-elevation-myocardial-infarction-in-elderly-patients/" title="Read more" >...</a>

angulación aórtica post TAVR

TAVI in Horizontal Aorta: Neo2 vs. Sapien Ultra

There are controversies regarding transcatheter aortic valve implantation (TAVI) in cases of challenging anatomical complexity, such as horizontal aorta (HA). This is primarily because aortic angulation (AA) impacts the procedure differently depending on the valve type used. As previously studied, angulation complicates crossing, implantation, and coaxial positioning with commissural alignment. In the study presented by<a href="https://solaci.org/en/2024/06/24/tavi-in-horizontal-aorta-neo2-vs-sapien-ultra/" title="Read more" >...</a>

Top